Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | -0.74% | -5.64% | -9.07% |
05-16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
04-29 | AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.07% | 20.51M | |
+9.65% | 115B | |
+11.91% | 106B | |
-2.59% | 21.96B | |
-13.89% | 21.87B | |
-5.29% | 19.21B | |
-3.42% | 18.08B | |
-38.57% | 17.71B | |
+6.21% | 14.32B | |
+33.74% | 12.42B |
- Stock Market
- Equities
- AIM Stock
- News AIM ImmunoTech Inc.
- Transcript : Hemispherx Biopharma, Inc., Q2 2016 Earnings Call, Aug 19, 2016